Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · Real-Time Price · USD
7.16
+0.15 (2.07%)
Dec 20, 2024, 4:00 PM EST - Market closed
Mind Medicine (MindMed) Employees
Mind Medicine (MindMed) had 57 employees as of December 31, 2023. The number of employees increased by 9 or 18.75% compared to the previous year.
Employees
57
Change (1Y)
9
Growth (1Y)
18.75%
Revenue / Employee
n/a
Profits / Employee
-$1,715,825
Market Cap
525.05M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 57 | 9 | 18.75% |
| Dec 31, 2022 | 48 | 7 | 17.07% |
| Dec 31, 2021 | 41 | 19 | 86.36% |
| Dec 31, 2020 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 1,218 |
| Phathom Pharmaceuticals | 452 |
| Sangamo Therapeutics | 405 |
| Xeris Biopharma Holdings | 377 |
| Semler Scientific | 92 |
| CorMedix | 83 |
| Astria Therapeutics | 59 |
| Tourmaline Bio | 44 |
MNMD News
- 2 days ago - MindMed to Be Added to the Nasdaq Biotechnology Index - Business Wire
- 5 days ago - MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD) - Business Wire
- 10 days ago - MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress - Business Wire
- 16 days ago - MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD) - Business Wire
- 18 days ago - MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy - Business Wire
- 19 days ago - MindMed Announces New Employee Inducement Grants - Business Wire
- 4 weeks ago - MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer - Business Wire
- 5 weeks ago - MindMed to Participate in Upcoming Investor Conferences - Business Wire